1557 – Human tissue (surgical) wound treatments – Laminectomy and tendon repair (AmnioFix, AmnioWrap and AmnioFix Injectable)

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status -
  • Type -
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome -

Application details

Reason for application

Amendment to MBS item(s).

Service or technology in this application

The proposed medical service is the modulation of inflammation, reduction of scar tissue formation, and the enhancement of healing by the application of a bioactive tissue matrix allograft composed of dehydrated human amnion/chorion membrane (dHACM).

Type: Therapeutic

Medical condition this application addresses

This application concerns the use of alternative anti-adhesion and scarring prevention prostheses in medical conditions treated by procedures currently listed on the MBS.

Application documents

Meetings to consider this application

  • PASC meeting: 6 to 7 December 2018
  • ESC meeting: -
  • MSAC meeting: -